COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,577 Articles (22,415 medRxiv, 8,162 bioRxiv)

Most recent first Previous |  Page 2112: Articles 21111-21120  | Next

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
Mason, C. Y., Kanitkar, T., Richardson, C. J., Lanzman, M., Stone, Z., Mahungu, T., Mack, D., Wey, E. Q., Lamb, L., Balakrishnan, I., Pollara, G.
10.1101/2020.10.09.20199778 — Posted: 2020-10-11
Age-targeted dose allocation can halve COVID-19 vaccine requirements
Meehan, M. T., Cocks, D. G., Caldwell, J. M., Trauer, J. M., Adekunle, A. I., Ragonnet, R. R., McBryde, E. S.
10.1101/2020.10.08.20208108 — Posted: 2020-10-11
Extended laboratory panel testing in the Emergency Department for risk-stratification of patients with COVID-19: a single centre retrospective service evaluation
Ponsford, M. J., Burton, R. J., Smith, L., Khan, P., Andrews, R., Cuff, S., Tan, L., Eberl, M., Humphreys, I. R., Babolhavaeji, F., Artemiou, A., Pandey, M., Jolles, S., Underwood, J.
10.1101/2020.10.06.20205369 — Posted: 2020-10-11
Risk of death during the 2020 UK COVID-19 epidemic among people with rare autoimmune diseases compared to the general population. Preliminary results from the RECORDER project.
Peach, E. J., Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R. B., Aston, J., Bythell, M., Stevens, S., Pearce, F. A.
10.1101/2020.10.09.20210237 — Posted: 2020-10-11
Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis
Cheng, D., Calderwood, C., Skyllberg, E., Ainley, A.
10.1101/2020.10.08.20193623 — Posted: 2020-10-11
A Comparative COVID 19 Characterizations and Clinical Course Analysis between ICU and Non ICU Settings
Patel, A., Bhatt, P., Madan, S., Shah, N., Thakkar, V., Shah, B., Chovatia, R., Shah, H., Patel, M., Dabhi, P., Nanavati, A., Chag, M., Parikh, K.
10.1101/2020.10.07.20208389 — Posted: 2020-10-11
SARS-CoV-2 infections in Italian schools: preliminary findings after one month of school opening during the second wave of the pandemic
Buonsenso, D., De Rose, C., Moroni, R., Valentini, P.
10.1101/2020.10.10.20210328 — Posted: 2020-10-11
District level correlates of COVID-19 pandemic in India
Tamrakar, V., Srivastava, A., Parmar, M. C., Shukla, S. K., Shabnam, S., Boro, B., Saha, A., Debbarma, B., Saikia, N.
10.1101/2020.10.08.20208447 — Posted: 2020-10-11 Discussion: Onsite
Prevalence and Longevity of SARS-CoV-2 Antibodies in Healthcare Workers: A Single Center Study
Brant-Zawadzki, M., Fridman, D., Robinson, P., Zahn, M., Chau, C., German, R., Breit, M., Burke, E., Bock, J. R., Hara, J.
10.1101/2020.10.09.20210229 — Posted: 2020-10-11
Transplacental Transfer of SARS-CoV-2 Antibodies
Flannery, D. D., Gouma, S., Dhudasia, M. B., Mukhopadhyay, S., Pfeifer, M. R., Woodford, E. C., Triebwasser, J. E., Gerber, J. S., Morris, J. S., Weirick, M. E., McAllister, C. M., Bolton, M. J., Arevalo, C. P., Anderson, E. M., Goodwin, E. C., Hensley, S., Puopolo, K. M.
10.1101/2020.10.07.20207480 — Posted: 2020-10-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).